This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Persani, L. Articles by Beck-Peccoz, P. Search for Related Content PubMed PubMed Citation Articles by Persani, L. Articles by Beck-Peccoz, P.

Circulating Thyrotropin Bioactivity in Sporadic Central Hypothyroidism¹

Institute of Endocrine Sciences, University of Milan, Istituto Auxologico Italiano Instituto di Ricovero e Cura a Carattere Scientifico (L.P.), and Ospedale Maggiore Instituto di Ricovero e Cura a Carattere Scientifico (S.B., G.F., P.B.-P.), 20145 Milan; and Department of Clinical Science, Endocrinology, University of Rome La Sapienza (E.F.), 00100 Rome, Italy

Address all correspondence and requests for reprints to: Luca Persani, M.D., Ph.D., Laboratorio di Ricerche Endocrinologiche, Istituto Auxologico Italiano Instituto di Ricovero e Cura a Carattere Scientifico, Via Ariosto 13, 20145 Milan, Italy. E-mail: persani{at}auxologico.it

The etiopathogenesis of sporadic central hypothyroidism (CH) involves pituitary and hypothalamic lesions. Pituitary CH (pCH) implies a diminished number of functioning thyrotropes, accounting for the quantitative impairment of TSH secretion. Hypothalamic CH (hCH) is characterized by normal or even increased TSH concentrations and qualitative abnormalities of TSH secretion, including a decreased bioactivity of circulating TSH. However, controversy still exists about the actual occurrence of bioinactive TSH among CH patients, and no data are available in pCH. Therefore, we studied 41 CH patients with different hypothalamic-pituitary disorders. Immunoreactive TSH (TSH-I) ranged from 0.08–11.1 mU/L (normal, 0.24–4.0), free T₄ (FT₄) ranged from 0.6–8.8 pmol/L (normal, 9–18), and FT₃ ranged from 1.2–5.4 pmol/L (normal, 4–8). A blunted TSH response to TRH (<4 mU/L), indicating prevalent pCH, was found in 56% of the patients, and a net TSH-I increment 4 mU/L, indicating prevalent hCH, was found in the remaining 44%. Net TSH-I increments showed significant correlation with basal FT₄ (P < 0.02), indicating the relevance of pituitary TSH reserve in the pathogenesis of CH. Circulating TSH was immunoconcentrated and tested in bioassay and in ricin affinity chromatography. The ratio between biological (B) and immunological (I) activities of circulating TSH was reduced (n = 25; TSH B/I, 0.38 ± 0.19) compared to the values recorded in normal subjects (n = 26; TSH B/I, 1.53 ± 0.54; P < 0.001) and primary hypothyroid patients (n = 24; TSH B/I, 0.74 ± 0.31; P < 0.001), but no difference between pCH (n = 9; 0.36 ± 0.16) and hCH (n = 16; 0.39 ± 0.20) was seen. TSH B/I values in CH patients showed a limited overlap with normal values (20%) and a highly significant correlation with the FT₃ response to endogenous TRH-stimulated TSH (P < 0.005). The elevated sialylation degree of TSH molecules may explain part of these findings.

In conclusion, the secretion of TSH molecules with reduced bioactivity is a common alteration in the patients with hypothalamic-pituitary lesions, contributing along with the impairment of pituitary TSH reserve to the pathogenesis of CH.

This article has been cited by other articles:

				H. Filipsson and G. Johannsson GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies Eur. J. Endocrinol., November 1, 2009; 161(S1): S85 - S95. [Abstract] [Full Text] [PDF]

				M. Bonomi, M. Busnelli, P. Beck-Peccoz, D. Costanzo, F. Antonica, C. Dolci, A. Pilotta, F. Buzi, and L. Persani A Family with Complete Resistance to Thyrotropin-Releasing Hormone N. Engl. J. Med., February 12, 2009; 360(7): 731 - 734. [Full Text] [PDF]

				H. Filipsson, E. Nystrom, and G. Johannsson Exploring the use of recombinant human TSH in the diagnosis of central hypothyroidism Eur. J. Endocrinol., August 1, 2008; 159(2): 153 - 160. [Abstract] [Full Text] [PDF]

				D. Preiss, L. Todd, and M. Panarelli Diagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test results Ann Clin Biochem, January 1, 2008; 45(1): 70 - 75. [Abstract] [Full Text] [PDF]

				A. A. Nikrodhanond, T. M. Ortiga-Carvalho, N. Shibusawa, K. Hashimoto, X. H. Liao, S. Refetoff, M. Yamada, M. Mori, and F. E. Wondisford Dominant Role of Thyrotropin-releasing Hormone in the Hypothalamic-Pituitary-Thyroid Axis J. Biol. Chem., February 24, 2006; 281(8): 5000 - 5007. [Abstract] [Full Text] [PDF]

				K. H. Darzy and S. M. Shalet Circadian and Stimulated Thyrotropin Secretion in Cranially Irradiated Adult Cancer Survivors J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6490 - 6497. [Abstract] [Full Text] [PDF]

				W. T. Gibson, I. S. Farooqi, M. Moreau, A. M. DePaoli, E. Lawrence, S. O'Rahilly, and R. A. Trussell Congenital Leptin Deficiency Due to Homozygosity for the {Delta}133G Mutation: Report of Another Case and Evaluation of Response to Four Years of Leptin Therapy J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4821 - 4826. [Abstract] [Full Text] [PDF]

				A. Mehta, P. C. Hindmarsh, R. G. Stanhope, C. E. Brain, M. A. Preece, and M. T. Dattani Is the Thyrotropin-Releasing Hormone Test Necessary in the Diagnosis of Central Hypothyroidism in Children J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5696 - 5703. [Abstract] [Full Text] [PDF]

				L. Alberti, M. C. Proverbio, S. Costagliola, R. Romoli, B. Boldrighini, M. C. Vigone, G. Weber, G. Chiumello, P. Beck-Peccoz, and L. Persani Germline Mutations of TSH Receptor Gene as Cause of Nonautoimmune Subclinical Hypothyroidism J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2549 - 2555. [Abstract] [Full Text] [PDF]

				M. Bonomi, M. C. Proverbio, G. Weber, G. Chiumello, P. Beck-Peccoz, and L. Persani Hyperplastic Pituitary Gland, High Serum Glycoprotein Hormone {{alpha}}-Subunit, and Variable Circulating Thyrotropin (TSH) Levels as Hallmark of Central Hypothyroidism due to Mutations of the TSH{beta} Gene J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1600 - 1604. [Abstract] [Full Text]